These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5462887)

  • 1. [Studies on mode of action of monoamine oxidase inhibitors on the experimental hypertension of the rat].
    Nagata C
    Nihon Naika Gakkai Zasshi; 1970 Apr; 59(4):319-28. PubMed ID: 5462887
    [No Abstract]   [Full Text] [Related]  

  • 2. [Adrenergic amines and monoaminoxidases in essential arterial hypertension].
    Sicuteri F; Buffoni F; Michelacci S; Del Bene E
    Acta Vitaminol Enzymol; 1969; 23(1):45-63. PubMed ID: 4896867
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anti-monoamine-oxidase activity of some beta-acyl-phenylhydrazines].
    Arrigo Reina R; Mazzone G
    Boll Soc Ital Biol Sper; 1970 Dec; 46(24):1041-4. PubMed ID: 5519865
    [No Abstract]   [Full Text] [Related]  

  • 4. Antihypertensive and monoamine oxidase inhibitory activity of 3-amino-2-oxazolidinone (3AO) and its condensation product with 2-substituted-3-formyl-4-oxo-(4H) pyrido(1,2-a)pyrimidines.
    Kaul CL; Grewal RS
    Biochem Pharmacol; 1972 Feb; 21(3):303-16. PubMed ID: 5014489
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinico-pharmacological model of paroxysmal arterial hypertension].
    Sicuteri F; Del Bene E; Tarquini B; Fanciullacci M
    Rass Neurol Veg; 1968; 22(1):63-82. PubMed ID: 5718883
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of the reserpine effect on rat salivary gland noradrenaline by inhibitors of monoamine oxidase and catechol-O-methyl transferase.
    Jonason J
    J Pharm Pharmacol; 1970 Feb; 22(2):93-5. PubMed ID: 4392262
    [No Abstract]   [Full Text] [Related]  

  • 7. New contributions from basic science to understanding the effects of monoamine oxidase inhibiting antidepressants.
    Murphy DL; Garrick NA; Aulakh CS; Cohen RM
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):37-43. PubMed ID: 6735994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of 2 N-substituted aminotetralin derivatives with antihypertensive action on the monoamine oxidase activity of brain and liver preparations].
    Bogoslovova T; Staneva-Stoĭcheva D
    Eksp Med Morfol; 1987; 26(4):40-4. PubMed ID: 3128443
    [No Abstract]   [Full Text] [Related]  

  • 9. [Monoamine oxidase and essential arterial hypertension].
    Sicuteri F; Del Bene E; Anselmi B; Del Bianco PL
    Boll Soc Ital Biol Sper; 1967 Sep; 43(17):1055-8. PubMed ID: 6077438
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of L-dopa and inhibitors of decarboxylase and monoamine oxidase on brain noradrenaline levels and blood pressure in spontaneously hypertensive rats.
    Yamori Y; De Jong W; Yamabe H; Lovenberg W; Sjoerdsma A
    J Pharm Pharmacol; 1972 Sep; 24(9):690-5. PubMed ID: 4404071
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of selective monoamine oxidase inhibitors on rat brain mitochondrial monoamine oxidase during hyperbaric oxygenation.
    Goroshinskaya IA; Bronovizkaya ZG; Gorkin VZ
    Commun Psychopharmacol; 1977; 1(1):39-47. PubMed ID: 606471
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of monoamine oxidase inhibition on the regional cerebral blood flow response to circulating noradrenaline.
    Lasbennes F; Lacombe P; Seylaz J
    Brain Res; 1988 Jun; 454(1-2):205-11. PubMed ID: 3409003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive and monoamine oxidase inhibitory activity of some derivatives of 3-formyl-4-oxo-4H-pyrido (1,2-a) pyrimidine.
    George T; Kaul CL; Grewal RS; Tahilramani R
    J Med Chem; 1971 Oct; 14(10):913-5. PubMed ID: 4398920
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical pharmacology of reversible monoamine oxidase-A inhibitors.
    Bieck PR; Antonin KH; Schmidt E
    Clin Neuropharmacol; 1993; 16 Suppl 2():S34-41. PubMed ID: 8313395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Debrisoquin, a selective inhibitor of intraneuronal monoamine oxidase in man.
    Pettinger WA; Korn A; Spiegel H; Solomon HM; Pocelinko R; Abrams WB
    Clin Pharmacol Ther; 1969; 10(5):667-74. PubMed ID: 5808462
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular baroreceptor activity and selective inhibition of monoamine oxidase.
    Bar-Am O; Gross A; Friedman R; Finberg JP
    Eur J Pharmacol; 2012 May; 683(1-3):226-30. PubMed ID: 22465184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Overview of Analytical Methods for the Determination of Monoamine Oxidase Inhibitors in Pharmaceutical Formulations and Biological Fluids.
    Saka C
    Crit Rev Anal Chem; 2017 Jan; 47(1):1-23. PubMed ID: 27715253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rat heart monoamine oxidase: antagonism between d-amphetamine, oleic and arachidonic acids and monoamine oxidase inhibitors.
    Sen R; Parmar SS; Guha SR
    Proc West Pharmacol Soc; 1979; 22():109-13. PubMed ID: 515037
    [No Abstract]   [Full Text] [Related]  

  • 19. Brain and vascular monoamine oxidase activity in the deoxycorticosterone-salt hypertensive rat.
    Lai FM; Spector S
    Br J Pharmacol; 1977 Mar; 59(3):393-5. PubMed ID: 843681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. antihypertensive and monoamine oxidase inhibitory activity of some azacycloalkyl-substituted benzaldehyde hydrazone derivatives.
    George T; Kaul CL; Grewal RS; Mehta DV
    J Med Chem; 1971 Oct; 14(10):909-13. PubMed ID: 4398919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.